## Core Concept
Chronic Lymphocytic Leukemia (CLL) is a type of cancer characterized by the progressive accumulation of mature, but functionally incompetent, lymphocytes in the blood, bone marrow, and lymphoid tissues. It is the most common type of leukemia in adults, particularly affecting individuals over the age of 60. CLL is distinguished by its indolent course and specific immunophenotypic profile.

## Why the Correct Answer is Right
The correct answer, although not directly provided, would relate to a statement that does not align with established facts about CLL. Typically, CLL cells express specific surface markers, including CD5, CD19, CD20, and CD23, and have a characteristic immunoglobulin light chain restriction. CLL is known for its slow progression and variable clinical course, ranging from indolent to aggressive forms.

## Why Each Wrong Option is Incorrect
- **Option A:** Without specific details on option A, we can infer that any statement contradicting CLL's typical presentation, such as its age of onset, common symptoms (e.g., lymphadenopathy, fatigue), or diagnostic markers (e.g., CD5+, CD23+), would be incorrect.
- **Option B:** Similarly, any statement misrepresenting CLL's pathophysiology, such as its cell of origin (mature B cells), the role of genetic mutations (e.g., del(13q14), trisomy 12), or common clinical manifestations, would be incorrect.
- **Option C:** A statement contradicting established treatment approaches for CLL, such as the use of targeted therapies (e.g., ibrutinib, venetoclax), chemotherapy, or supportive care, would also be incorrect.
- **Option D:** This would pertain to a statement about CLL that is misleading or not supported by clinical evidence, such as its prognosis, which can be stratified using markers like the Rai or Binet staging systems.

## Clinical Pearl / High-Yield Fact
A key point to remember is that CLL cells often express **CD5**, which is more typical of T cells but also found on CLL B cells, aiding in the differential diagnosis. CLL is also notable for its association with **immunoglobulin heavy chain variable region (IGHV) mutation status**, which has significant prognostic implications. Patients with mutated IGHV tend to have a more indolent disease course.

## Correct Answer: D.